Prenatal exposure to phentermine-topiramate lower under safety program

Under the Risk Evaluation and Mitigation Strategy (REMS), prenatal exposure to phentermine-topiramate is lower than topiramate and other antiobesity medications (AOMs), according to a study published online March 21 in the Annals of Internal Medicine.

source https://medicalxpress.com/news/2023-03-prenatal-exposure-phentermine-topiramate-safety.html